| Target Price | $7.14 |
| Price | $3.96 |
| Potential |
80.30%
register free of charge
|
| Number of Estimates | 6 |
|
6 Analysts have issued a price target Outset Medical Inc 2027 .
The average Outset Medical Inc target price is $7.14.
This is
80.30%
register free of charge
$10.50
165.15%
register free of charge
$6.06
53.03%
register free of charge
|
|
| A rating was issued by 11 analysts: 9 Analysts recommend Outset Medical Inc to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Outset Medical Inc stock has an average upside potential 2027 of
80.30%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 119.48 | 129.78 |
| 5.09% | 8.62% | |
| EBITDA Margin | -52.20% | -36.27% |
| 42.20% | 30.52% | |
| Net Margin | -68.34% | -46.06% |
| 39.29% | 32.60% |
6 Analysts have issued a sales forecast Outset Medical Inc 2026 . The average Outset Medical Inc sales estimate is
This results in the following potential growth metrics:
5 Analysts have issued an Outset Medical Inc EBITDA forecast 2026. The average Outset Medical Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
6 Outset Medical Inc Analysts have issued a net profit forecast 2026. The average Outset Medical Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -5.37 | -3.18 |
| 85.47% | 40.78% | |
| P/E | negative | |
| EV/Sales | 0.20 |
6 Analysts have issued a Outset Medical Inc forecast for earnings per share. The average Outset Medical Inc EPS is
This results in the following potential growth metrics and future valuations:
Outset Medical Inc...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| BTIG |
Locked
➜
Locked
|
Locked | Feb 12 2026 |
| Stifel |
Locked
➜
Locked
|
Locked | Jan 07 2026 |
| BTIG |
Locked
➜
Locked
|
Locked | Dec 16 2025 |
| BTIG |
Locked
➜
Locked
|
Locked | Nov 11 2025 |
| RBC Capital |
Locked
➜
Locked
|
Locked | Nov 11 2025 |
| Stifel |
Locked
➜
Locked
|
Locked | Nov 11 2025 |
| RBC Capital |
Locked
➜
Locked
|
Locked | Aug 19 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
BTIG:
Locked
➜
Locked
|
Feb 12 2026 |
|
Locked
Stifel:
Locked
➜
Locked
|
Jan 07 2026 |
|
Locked
BTIG:
Locked
➜
Locked
|
Dec 16 2025 |
|
Locked
BTIG:
Locked
➜
Locked
|
Nov 11 2025 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
Nov 11 2025 |
|
Locked
Stifel:
Locked
➜
Locked
|
Nov 11 2025 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
Aug 19 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


